We are live on ! Find out more
IRD

Opus Genetics
IRD

41 hedge funds and large institutions have $6.69M invested in Opus Genetics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

201% more call options, than puts

Call options by funds: $238K | Put options by funds: $79K

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

3% more funds holding

Funds holding: 40 → 41 (+1)

0% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 10

1.65% less ownership

Funds ownership: 12.54% → 10.9% (-1.6%)

17% less capital invested

Capital invested by funds: $8.07M → $6.69M (-$1.38M)

Holders
41
Holders Change
+1
Holders Change %
+2.5%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
10
Reduced
10
Closed
8
Calls
$238K
Puts
$79K
Net Calls
+$159K
Net Calls Change
-$720K

Top Buyers

Rank Fund Capital Flow
1
RB
Richmond Brothers
Michigan
+$172K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$133K
3
Ameriprise
Ameriprise
Minnesota
+$102K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$53.4K
5
SSA
Schonfeld Strategic Advisors
New York
+$47.9K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$245K
2
Two Sigma Investments
Two Sigma Investments
New York
-$233K
3
Millennium Management
Millennium Management
New York
-$177K
4
DC
Diametric Capital
Massachusetts
-$130K
5
PCM
Prelude Capital Management
New York
-$82.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Cornerstone Capital
California
$37K – – –
Simplex Trading
27
Simplex Trading
Illinois
$33K +$35.1K +10,243 New
KPWS
28
Kestra Private Wealth Services
Texas
$32K +$34.2K +10,000 New
MA
29
MCF Advisors
Kentucky
$31K +$32.5K +9,499 New
SWM
30
Spire Wealth Management
Virginia
$29K +$30.8K +9,002 New
UBS Group
31
UBS Group
Switzerland
$19K -$4.78K -1,397 -20%
Wells Fargo
32
Wells Fargo
California
$9K +$9.55K +2,790 +2,735%
CAPTRUST Financial Advisors
33
CAPTRUST Financial Advisors
North Carolina
$5K +$5.13K +1,500 New
CWM
34
CarsonAllaria Wealth Management
Illinois
$3K – – –
APC
35
Aspire Private Capital
North Carolina
$1K – – –
First Manhattan
36
First Manhattan
New York
$1K – – –
Millennium Management
37
Millennium Management
New York
– -$177K -47,431 Closed
Renaissance Technologies
38
Renaissance Technologies
New York
– -$72K -19,361 Closed
LPL Financial
39
LPL Financial
California
– -$56K -15,004 Closed
Squarepoint
40
Squarepoint
New York
– -$40K -10,655 Closed
Osaic Holdings
41
Osaic Holdings
Arizona
– -$15.4K -4,500 -100%
BAM
42
Byrne Asset Management
New Jersey
– -$8K -2,176 Closed
Group One Trading
43
Group One Trading
Illinois
– -$2.7K -790 Closed
Citigroup
44
Citigroup
New York
– +$226 +66 New
CG
45
Cutler Group
California
– +$342 +100 +100%
1
2

IRD Hedge Fund Activity: Q1 2022 in Review

41 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2022, worth a combined $6.69M — down 17% from $8.07M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new IRD positions and 8 closed out — a net gain of 2 holders — while 10 added to existing stakes and 10 trimmed.

The largest buyer was Richmond Brothers, adding an estimated $172K. The largest seller was Two Sigma Advisers, cutting an estimated $245K.

  • 41 institutional investors held Opus Genetics (IRD) as of Q1 2022, up from 40 in Q4 2021.
  • Funds reported $6.69M of Opus Genetics stock for Q1 2022, down 17% quarter-over-quarter.
  • 10 funds opened new Opus Genetics positions in Q1 2022 and 8 closed out, a net change of +2 holders.
  • The largest Opus Genetics buyer in Q1 2022 was Richmond Brothers, an estimated $172K added.
  • The largest Opus Genetics seller in Q1 2022 was Two Sigma Advisers, an estimated $245K sold.

Based on aggregated 13F filings for Q1 2022.